Provided by Tiger Trade Technology Pte. Ltd.

Propanc Biopharma, Inc.

0.1108
-0.0070-5.94%
Post-market: 0.11500.0042+3.79%19:57 EDT
Volume:3.87M
Turnover:454.99K
Market Cap:1.76M
PE:-0.01
High:0.1200
Open:0.1140
Low:0.1068
Close:0.1178
52wk High:11.00
52wk Low:0.1068
Shares:15.86M
Float Shares:6.73M
Volume Ratio:2.21
T/O Rate:57.48%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-13.5424
EPS(LYR):-14.8490
ROE:-1811.69%
ROA:-535.73%
PB:0.17
PE(LYR):-0.01

Loading ...

Jul 25, 2025

Correspondence

Form CORRESP - Correspondence
Jul 25, 2025

Correspondence

Form CORRESP - Correspondence
Jul 22, 2025

Major Issues Report

Form 8-K - Current report
Jun 27, 2025

Major Issues Report

Form 8-K - Current report
Jun 18, 2025

Major Issues Report

Form 8-K - Current report
Jun 02, 2025

Major Issues Report

Form 8-K - Current report
May 30, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 15, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 08, 2025

Major Issues Report

Form 8-K - Current report
Apr 25, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 21, 2025

Major Issues Report

Form 8-K - Current report
Apr 08, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Apr 02, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 31, 2025

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Mar 18, 2025

Major Issues Report

Form 8-K - Current report
Feb 14, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Feb 12, 2025

Major Issues Report

Form 8-K - Current report
Dec 20, 2024

Major Issues Report

Form 8-K - Current report
Dec 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]